Targeting integrins for the control of tumour angiogenesis

By Akalu Abebe   Cretu Alexandra   Brooks Peter C  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1475-1486

Informa Healthcare

Access to resources Recommend Favorite

Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

By Seystahl Katharina   Weller Michael  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 605-617

Informa Healthcare

Access to resources Recommend Favorite

Tumor Angiogenesis: A Potential Target In Cancer Control by Phytochemicals

By  

Current Cancer Drug Targets, Vol. 3, Iss. 3, 2003-06 ,pp. : 205-217

Bentham Science Publishers

Access to resources Recommend Favorite

Chondromodulin-I and Tenomodulin: The Negative Control of Angiogenesis in Connective Tissue

By  

Current Pharmaceutical Design, Vol. 13, Iss. 20, 2007-07 ,pp. : 2101-2112

Bentham Science Publishers

Access to resources Recommend Favorite

PI-3 Kinase-PTEN Signaling Node: An Intercept Point for the Control of Angiogenesis

By  

Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. : 380-388

Bentham Science Publishers

Access to resources Recommend Favorite